Rising Opportunities in the Emerging Markets to Boost the Growth of the Regenerative Medicine Market

The report “Regenerative Medicine Market by Therapy (Cell Therapy, Tissue Engineering, Immunotherapy, Gene Therapy), Product (Cell-Based, Acellular), Applications (Orthopedic & Musculoskeletal Disorders, Dermatology, Oncology, Cardiology) — Forecast to 2021”, report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the Regenerative Medicine Market along with the estimates and forecasts of the revenue and market share analysis.

The Global Regenerative Medicine Market is expected to reach the US $38.70 Billion, at a CAGR of 23.6%. The major factor driving the growth of this market, our government and private funding to support the development of regenerative medicine, the rising prevalence of chronic diseases and genetic disorders, increase in global healthcare expenditure, and rapid growth in the aging population.

Download PDF Brochure (Regenerative Medicines Market):https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65442579

The report segments this market based on types, therapy, application, and regions.

Ethical concerns with the use of embryonic stem cell for R&D is a major factor restraining the growth of the market. Research in regenerative medicine necessitates the use of animals and humans in gene therapy studies that involve the recombination of genes and stem cell research therapies. These cells are also used for in vivo toxicity and pharmacokinetic testing of drugs that may harm animals and humans. In addition, stem cell research studies use human embryos for clinical applications that often lead to the destruction of the embryos.

Regenerative Medicine Market Dynamics:

Market Drivers:

• Government & Private Funding to Support the Development of Regenerative Medicine
• Rising Prevalence of Chronic Diseases and Genetic Disorders
• Increase in Global Healthcare Expenditure
• Rapid Growth in the Aging Population
• Increase in Corporate Partnerships to Accelerate Development and Commercialization of Regenerative Medicine

Market Restraints:

• Ethical Concerns with the Use of Embryonic Stem Cell for R&D
• Lack of Clear Regulatory Guidelines

Market Opportunities:

• Rising Demand for Organ Transplantation
• Strong Product Pipeline

By application, orthopedic & musculoskeletal disorders, dermatology, cardiology, diabetes, central nervous system diseases, and other applications. Oncology is expected to account the fastest growing market owing to increasing prevalence of cancer globally and rich product pipeline and increasing demand for cancer treatments.

Browse 87 market data tables and 38 figures spread through 137 pages and in-depth TOC on “Regenerative Medicine Market”
 https://www.marketsandmarkets.com/Market-Reports/regenerative-medicine-market-65442579.html

Based on regions, the global Regenerative Medicine Market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this regional segment is driven by factors such as technological advancement in the Regenerative medicine and rising incidences of chronic diseases and aging population.

Key players in the Regenerative Medicine Market include Organogenesis Inc. (U.S.), Osiris Therapeutics, Inc. (U.S.), Vericel Corporation (U.S.), Stryker Corporation (U.S.), and NuVasive, Inc. (U.S.), Medtronic (Ireland), Acelity (KCI Concepts) (U.S.), Integra LifeSciences (U.S.), Cook Biotech Inc. (U.S.), and C.R. Bard (U.S.).